Antibody landscapes after influenza virus infection or vaccination JM Fonville, SH Wilks, SL James, A Fox, M Ventresca, M Aban, L Xue, ... Science 346 (6212), 996-1000, 2014 | 460 | 2014 |
The potential for respiratory droplet–transmissible A/H5N1 influenza virus to evolve in a mammalian host CA Russell, JM Fonville, AEX Brown, DF Burke, DL Smith, SL James, ... Science 336 (6088), 1541-1547, 2012 | 397 | 2012 |
Dengue viruses cluster antigenically but not as discrete serotypes LC Katzelnick, JM Fonville, GD Gromowski, JB Arriaga, A Green, ... Science 349 (6254), 1338-1343, 2015 | 238 | 2015 |
Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 141 | 2022 |
Selection of antigenically advanced variants of seasonal influenza viruses C Li, M Hatta, DF Burke, J Ping, Y Zhang, M Ozawa, AS Taft, SC Das, ... Nature Microbiology 1, 16058, 2016 | 64 | 2016 |
Can goal-setting for patients with multimorbidity improve outcomes in primary care? Cluster randomised feasibility trial JA Ford, E Lenaghan, C Salter, D Turner, A Shiner, AB Clark, J Murdoch, ... BMJ open 9 (6), e025332, 2019 | 35 | 2019 |
Influenza B vaccine lineage selection—An optimized trivalent vaccine AM Höpping, JM Fonville, CA Russell, S James, DJ Smith Vaccine 34 (13), 1617-1622, 2016 | 22 | 2016 |
Antigenic Relationships among Human Pathogenic Orientia tsutsugamushi Isolates from Thailand SL James, SD Blacksell, P Nawtaisong, A Tanganuchitcharnchai, ... PLoS neglected tropical diseases 10 (6), e0004723, 2016 | 18 | 2016 |